ADPT - CIK 0001478320
Adaptive Biotechnologies Corp (ADPT) reported revenue of $276.98M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $276.98M | +54.8% |
| FY 2024 | $178.96M | +5.1% |
| FY 2023 | $170.28M | -8.1% |
| FY 2022 | $185.31M | +20.1% |
| FY 2021 | $154.34M | +56.9% |
| FY 2020 | $98.38M | +15.6% |
| FY 2019 | $85.07M | +52.8% |
| FY 2018 | $55.66M | +44.8% |
| FY 2017 |
Adaptive Biotechnologies Corp (ADPT) reported revenue of $276.98M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2017 and fiscal 2025, Adaptive Biotechnologies Corp's revenue grew from $38.45M to $276.98M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $38.45M |
| - |